Literature DB >> 4451815

Hyperglycaemia produced by the polyamines spermine and spermidine.

D J Anderson, G G Shaw.   

Abstract

1 Intravenous injection of rabbits with the polyamines spermine (10-30 mg/kg) and spermidine (50-90 mg/kg) produced hyperglycaemia.2 Given by intraventricular injection, spermine and spermidine gave rise to hyperglycaemia in doses 250-500 times smaller than those effective intravenously.3 Intraventricular injections of the polyamines also produced hyperglycaemia in rats. Adrenal demedullation abolished the response.4 In the rabbit, the hyperglycaemia resulting from intraventricular injection of polyamines was abolished in reserpine-treated animals. Anaesthesia had no effect on the response unless accompanied by anoxia, when the response was potentiated.5 Intracisternal injections of the polyamines in rabbits were less effective than intraventricular injections in that doses about four times larger were required to elicit an equivalent response.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451815      PMCID: PMC1776865          DOI: 10.1111/j.1476-5381.1974.tb09701.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Hyperglycaemia induced by drugs.

Authors:  A HASSELBLATT; D H SPROULL
Journal:  J Physiol       Date:  1961-06       Impact factor: 5.182

2.  Some pharmacological properties of the polyamines spermine and spermidine--a re-appraisal.

Authors:  G G Shaw
Journal:  Arch Int Pharmacodyn Ther       Date:  1972

3.  The regional distribution of the polyamines spermidine and spermine in brain.

Authors:  G G Shaw; A J Pateman
Journal:  J Neurochem       Date:  1973-04       Impact factor: 5.372

4.  The hyperglycaemic action of sodium salicylate.

Authors:  B B Gaitondé; S N Joglekar; S V Shaligram
Journal:  Br J Pharmacol Chemother       Date:  1967-08

5.  The hyperglycaemic effect of morphine.

Authors:  W Feldberg; S V Shaligram
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.